These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 21621695)

  • 1. The prevention and treatment of intestinal failure-associated liver disease in neonates and children.
    Nehra D; Fallon EM; Puder M
    Surg Clin North Am; 2011 Jun; 91(3):543-63. PubMed ID: 21621695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
    Cowles RA; Ventura KA; Martinez M; Lobritto SJ; Harren PA; Brodlie S; Carroll J; Jan DM
    J Pediatr Surg; 2010 Jan; 45(1):84-7; discussion 87-8. PubMed ID: 20105585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal failure-associated liver disease: what do we know today?
    Kelly DA
    Gastroenterology; 2006 Feb; 130(2 Suppl 1):S70-7. PubMed ID: 16473076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing parenteral nutrition liver disease.
    Kelly DA
    Early Hum Dev; 2010 Nov; 86(11):683-7. PubMed ID: 20923719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutritional management of infants with short bowel syndrome.
    Wessel JJ; Kocoshis SA
    Semin Perinatol; 2007 Apr; 31(2):104-11. PubMed ID: 17462495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of isolated liver transplantation for short bowel syndrome and intestinal failure-associated liver disease.
    Taha AM; Sharif K; Johnson T; Clarke S; Murphy MS; Gupte GL
    J Pediatr Gastroenterol Nutr; 2012 Apr; 54(4):547-51. PubMed ID: 22167020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal failure-associated liver disease in hospitalised children.
    Pichler J; Horn V; Macdonald S; Hill S
    Arch Dis Child; 2012 Mar; 97(3):211-4. PubMed ID: 22247247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal failure-associated liver disease (IFALD): insights into pathogenesis and advances in management.
    Lee WS; Chew KS; Ng RT; Kasmi KE; Sokol RJ
    Hepatol Int; 2020 May; 14(3):305-316. PubMed ID: 32356227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in the management of intestinal failure-associated liver disease.
    Wiles A; Woodward JM
    Curr Opin Clin Nutr Metab Care; 2009 May; 12(3):265-72. PubMed ID: 19339882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parenteral plant sterols and intestinal failure-associated liver disease in neonates.
    Kurvinen A; Nissinen MJ; Andersson S; Korhonen P; Ruuska T; Taimisto M; Kalliomäki M; Lehtonen L; Sankilampi U; Arikoski P; Saarela T; Miettinen TA; Gylling H; Pakarinen MP
    J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):803-11. PubMed ID: 22197940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
    Angsten G; Finkel Y; Lucas S; Kassa AM; Paulsson M; Lilja HE
    JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):587-95. PubMed ID: 22275330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short bowel syndrome and intestinal transplantation in children.
    Goulet O; Sauvat F
    Curr Opin Clin Nutr Metab Care; 2006 May; 9(3):304-13. PubMed ID: 16607133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal failure-associated liver disease in surgical infants requiring long-term parenteral nutrition.
    Bishay M; Pichler J; Horn V; Macdonald S; Ellmer M; Eaton S; Hill S; Pierro A
    J Pediatr Surg; 2012 Feb; 47(2):359-62. PubMed ID: 22325390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal failure-associated liver disease: management and treatment strategies past, present, and future.
    Carter BA; Karpen SJ
    Semin Liver Dis; 2007 Aug; 27(3):251-8. PubMed ID: 17682972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease.
    Sigalet D; Boctor D; Robertson M; Lam V; Brindle M; Sarkhosh K; Driedger L; Sajedi M
    Eur J Pediatr Surg; 2009 Dec; 19(6):348-53. PubMed ID: 19866409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of intravenous fish oil emulsions on pediatric intestinal failure-associated liver disease.
    Venick RS; Calkins K
    Curr Opin Organ Transplant; 2011 Jun; 16(3):306-11. PubMed ID: 21505340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Managing liver dysfunction in parenteral nutrition.
    Lloyd DA; Gabe SM
    Proc Nutr Soc; 2007 Nov; 66(4):530-8. PubMed ID: 17961274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome.
    Rollins MD; Scaife ER; Jackson WD; Meyers RL; Mulroy CW; Book LS
    Nutr Clin Pract; 2010 Apr; 25(2):199-204. PubMed ID: 20413701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel lipid-based approaches to pediatric intestinal failure-associated liver disease.
    Diamond IR; Pencharz PB; Feldman BM; Ling SC; Moore AM; Wales PW
    Arch Pediatr Adolesc Med; 2012 May; 166(5):473-8. PubMed ID: 22566549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of Omegaven in treating parenteral nutrition-associated liver disease.
    Park KT; Nespor C; Kerner J
    J Perinatol; 2011 Apr; 31 Suppl 1():S57-60. PubMed ID: 21448206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.